e-Participation on Guidelines of the Drug Safety Center
As part of Drug Safety Center’s commitment to ensuring that regulatory processes are transparent and inclusive. DSC announces the launch of a public consultation on the document titled Guideline on Public Consultation for Drug Safety Center Publications ans second e-publication is Guideline on Advertising of Medicines through eHealth Portal. This consultations aims to gather the opinions and feedback of the public regarding the guideline in order to ensure the clarity and comprehensiveness of its content.
-
To collect opinions and feedback from stakeholders.
-
To ensure the comprehensiveness of the guideline.
-
To enhance transparency and accountability in policy development.
-
To strengthen trust between the regulatory authority and the public.
-
To ensure alignment with international best practices
Drug Safety Center invites all citizens, residents, and stakeholders in the health sector to submit their comments and suggestions regarding the guideline by 11th of November, 2025 Drug Safety Center invites all citizens, residents, and stakeholders in the healthcare field to submit their comments and suggestions regarding Guideline on Public Consultation for Drug Safety Center Publications until November 24, 2025, and on Guideline on Advertising of Medicines until December 10, 2025.